We next determined the effects of the following a set of clinical parameters on the outcome of the entire group of analyzed patients: Prior broad-spectrum antimicrobial use, age, tumor histology, MetS, N:L ratio, obesity, PD-L1 expression, and smoking. This evidence concerns the gene CD274 and metabolic syndrome.